Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
Objective Current evidence on the effectiveness of SARS-CoV-2 prophylaxis is inconclusive. We aimed to systematically evaluate published studies on repurposed drugs for the prevention of laboratory-confirmed SARS-CoV-2 infection and/or COVID-19 among healthy adults.Design Systematic review.Eligibili...
Saved in:
| Main Authors: | Judith M Vonk, Eelko Hak, Katrien Oude Rengerink, Hubert G M Niesters, Debbie van Baarle, Maarten J Bijlsma, Guiling Zhou, Stefan Verweij, Stijn de Vos, Anna Maria Gerdina Pasmooij, Peter Mol |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-07-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/10/1/e001674.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation
by: Taichi Ochi, et al.
Published: (2024-01-01) -
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
by: Alexander Simonis, et al.
Published: (2020-11-01) -
FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry
by: Manisha Singh, et al.
Published: (2025-03-01) -
Drug repurposing: identification of SARS-CoV-2 potential inhibitors by virtual screening and pharmacokinetics strategies
by: Zubia Rashid, et al.
Published: (2024-04-01) -
A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infection
by: Fangyuan Chen, et al.
Published: (2021-08-01)